Detailed Information
Cited 7 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Safety and Preliminary Clinical Activity of Ropotrectinib ( TPX-0005), a ROS1/TRK/ALK Inhibitor, in Advanced ROS1 Fusion-Positive NSCLC
- Authors
- Lin, J[Lin, J.]; Kim, D[Kim, D.]; Drilon, A[Drilon, A.]; Doebele, R[Doebele, R.]; Lee, J[Lee, J.]; Zhu, V[Zhu, V.]; Ahn, M[Ahn, M.]; Lim, J[Lim, J.]; Stopatschinskaja, S[Stopatschinskaja, S.]; Cui, JJ[Cui, J. J.]; Hyman, D[Hyman, D.]; Camidge, R[Camidge, R.]; Ou, S[Ou, S.]; Shaw, A[Shaw, A.]; Cho, BC[Cho, B. C.]
- Issue Date
- Oct-2018
- Publisher
- ELSEVIER SCIENCE INC
- Keywords
- TPX-0005; G2032R; ros1
- Citation
- JOURNAL OF THORACIC ONCOLOGY, v.13, no.10, pp.S322 - S322
- Indexed
- SCIE
SCOPUS
- Journal Title
- JOURNAL OF THORACIC ONCOLOGY
- Volume
- 13
- Number
- 10
- Start Page
- S322
- End Page
- S322
- ISSN
- 1556-0864
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Medicine > Department of Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.